MCD
52
2
ES
34
3
LH
43
-2
NSC
60
3
CRM
67
2
ZION
65
2
BMY
60
2
XRX
44
3
PNC
64
4
HST
49
-9
HRB
57
5
DOW
44
10
WBA
48
4
BWA
48
2
STZ
54
-3
ADSK
70
2
IBM
58
-2
TJX
64
2
EXC
53
-3
EMN
60
4
MCD
52
2
ES
34
3
LH
43
-2
NSC
60
3
CRM
67
2
ZION
65
2
BMY
60
2
XRX
44
3
PNC
64
4
HST
49
-9
HRB
57
5
DOW
44
10
WBA
48
4
BWA
48
2
STZ
54
-3
ADSK
70
2
IBM
58
-2
TJX
64
2
EXC
53
-3
EMN
60
4
Financhill
Back

Biodexa Pharmaceuticals PLC Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
4.79
Seasonality Move:
-23.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Biodexa Pharmaceuticals PLC Price Quote

$4.79
+0.22 (+8.86%)
(Updated: November 23, 2024 at 5:26 AM ET)

Biodexa Pharmaceuticals PLC Key Stats

Sell
20
Biodexa Pharmaceuticals PLC (BDRX) is a Sell
Day range:
$4.20 - $4.97
52-week range:
$3.50 - $220.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.12
P/B ratio:
0.24%
Volume:
223.8K
Avg. volume:
527.6K
1-year change:
-92.86%
Market cap:
$2.7M
Revenue:
$474.1K
EPS:
$-74.6

How Much Does Biodexa Pharmaceuticals PLC Make?

Data Unavailable

Is Biodexa Pharmaceuticals PLC Growing As A Company?

Data Unavailable

Biodexa Pharmaceuticals PLC Stock Price Performance

What Is Biodexa Pharmaceuticals PLC 52-Week High & Low?

Biodexa Pharmaceuticals PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Biodexa Pharmaceuticals PLC?

Is Biodexa Pharmaceuticals PLC Cash Flow Positive?

  • What Is BDRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$9.7M
  • What Is Biodexa Pharmaceuticals PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.8M
  • What Is Biodexa Pharmaceuticals PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.3M

Biodexa Pharmaceuticals PLC Return On Invested Capital

Data Unavailable

Biodexa Pharmaceuticals PLC Earnings Date & Stock Price

Biodexa Pharmaceuticals PLC Competitors

Biodexa Pharmaceuticals PLC Dividend Yield

Biodexa Pharmaceuticals PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.02
Upside from Last Price: 75.39%

Major Shareholders

  • How many BDRX shares are owned by institutional investors?
    126.9K BDRX shares are owned by institutional investors
  • How many BDRX shares are owned by insiders?
    1.3M BDRX shares are owned by insiders